The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
1-(Phenylsulfonyl)-1H-benzotriazole ID: ALA4095965
Cas Number: 4106-18-7
PubChem CID: 750248
Max Phase: Preclinical
Molecular Formula: C12H9N3O2S
Molecular Weight: 259.29
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: O=S(=O)(c1ccccc1)n1nnc2ccccc21
Standard InChI: InChI=1S/C12H9N3O2S/c16-18(17,10-6-2-1-3-7-10)15-12-9-5-4-8-11(12)13-14-15/h1-9H
Standard InChI Key: ZMGFTNXUMSRNMD-UHFFFAOYSA-N
Molfile:
RDKit 2D
18 20 0 0 0 0 0 0 0 0999 V2000
10.9779 -4.1146 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
11.1945 -3.3192 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
10.3973 -3.5294 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.7193 -1.4659 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.7181 -2.2929 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4326 -2.7055 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4307 -1.0534 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.1458 -1.4622 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.1506 -2.2883 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.9378 -2.5390 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.4194 -1.8679 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.9299 -1.2025 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.0046 -3.4885 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.2587 -4.2712 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.0655 -4.4382 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.6146 -3.8218 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.3513 -3.0358 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.5452 -2.8727 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 2 0
4 5 2 0
5 6 1 0
6 9 2 0
8 7 2 0
7 4 1 0
8 9 1 0
9 10 1 0
10 11 1 0
11 12 2 0
12 8 1 0
10 2 1 0
2 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 13 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: YesOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 259.29Molecular Weight (Monoisotopic): 259.0415AlogP: 1.67#Rotatable Bonds: 2Polar Surface Area: 64.85Molecular Species: NEUTRALHBA: 5HBD: ┄#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): ┄#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: ┄CX LogP: 2.23CX LogD: 2.23Aromatic Rings: 3Heavy Atoms: 18QED Weighted: 0.70Np Likeness Score: -1.91
References 1. Singh D, Silakari O.. (2017) Sodium hydrogen exchanger inhibitory activity of benzotriazole derivatives., 126 [PMID:27750152 ] [10.1016/j.ejmech.2016.10.005 ] 2. Pagliero RJ, Kaiser M, Brun R, Nieto MJ, Mazzieri MR.. (2017) Lead selection of antiparasitic compounds from a focused library of benzenesulfonyl derivatives of heterocycles., 27 (17): [PMID:28789893 ] [10.1016/j.bmcl.2017.07.081 ] 3. Lee, Sunkyung S and 5 more authors. 2005-04-21 (5-Arylfuran-2-ylcarbonyl)guanidines as cardioprotectives through the inhibition of Na+/H+ exchanger isoform-1. [PMID:15828827 ] 4. Lee, Sunkyung S and 6 more authors. 2005-06-15 4-Substituted (benzo[b]thiophene-2-carbonyl)guanidines as novel Na+/H+ exchanger isoform-1 (NHE-1) inhibitors. [PMID:15914000 ] 5. Huber, John D JD and 19 more authors. 2012-08-23 Identification of a potent sodium hydrogen exchanger isoform 1 (NHE1) inhibitor with a suitable profile for chronic dosing and demonstrated cardioprotective effects in a preclinical model of myocardial infarction in the rat. [PMID:22803959 ]